• News

    Innovators Descend on Annual Pediatric HM Conference

    September 1, 2010

    More than 400 people attended the Pediatric Hospital Medicine annual conference July 22-25 in Minneapolis.

  • News

    Hospitalist/Intensivist Model Lowers Costs, Maintains Quality of Care

    September 1, 2010

    As the field of HM continues to mature, branch out, and is called upon to lead in the care of a larger cross-section of hospitalized patients, it is only natural that this includes the critically ill patient.

  • 1
    News

    In the Literature

    September 1, 2010

    The latest research you need to know

  • News

    Market Watch

    September 1, 2010

    New Generics Desloratadine tablets (generic Clarinex)1 Didanosine delayed-release capsules (Generic Videx EC)2 New Indications, Dosage Forms, and Recommendations Ganciclovir ophthalmic gel 0.15% (Zirgan) has been approved by the FDA for treating acute herpetic keratitis.3 The recommende

  • News

    What Are the Chances a Hospitalized Patient Will Survive In-Hospital Arrest?

    September 1, 2010

    Case A 66-year-old woman with metastatic, non-small-cell carcinoma of the lung, chronic obstructive pulmonary disease (COPD), and hypertension presents with progressive shortness of breath and back pain.

  • 1
    News

    Productivity Capacity

    September 1, 2010

    The beginning of what’s next in HM

  • 1
    News

    Hospital-Acquired Condition (HAC) Guidelines Produce $20M in Medicare Savings

    September 1, 2010

    Falls and trauma account for 34% of all HACs reported from October 2008 to June 2009, followed by vascular catheter-associated infection (16%) and catheter-associated UTIs (16%).

  • 1
    News

    In the Literature

    August 2, 2010

    Physician reviews of HM-related research, including risk factors for iatrogenic pneumothorax, residency acceptance and use of pharmaceutical industry funding, and early cholecystectomy outcomes for gallstone pancreatitis.

  • News

    Market Watch

    August 2, 2010

    New Drugs, Indications, Dosage Forms, and Approvals Hydromorphone extended-release tablets (Exalgo) have been approved by the FDA as a once-daily treatment for managing moderate to severe pain in opioid-tolerant patients needing continuous opioid analgesia for an extended period of time.1 This f

  • News

    How Should Hypertensive Emergencies Be Managed?

    August 2, 2010

    Case A 57-year-old male with hypertension and end-stage renal disease is brought into the ED by his family for evaluation of headache, nausea, blurry vision, and confusion. Blood pressure is 235/130 mmHg.